Faezeh Firuzpour

Faezeh Firuzpour

Auto-generated profile, based on publicly available information

Faezeh Firuzpour

USERN Office, Babol University of Medical Sciences, Babol, Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
BNBehnam Najafiyan
Behnam Najafiyan
ZHZahra Bokaii Hosseini
Zahra Bokaii Hosseini
SESamar Esmaelian
Samar Esmaelian
FFFaezeh Firuzpour
Faezeh Firuzpour
SAShiva Rahimipour Anaraki
Shiva Rahimipour Anaraki
MNMohsen Nabi-Afjadi
Mohsen Nabi-Afjadi
Lung cancer ranks among the most prevalent forms of cancer and remains a significant factor in cancer-related mortality across the world. It poses significant challenges to healthcare systems and society as a whole due to its high incidence, mortality rates, and late-stage diagnosis. Resveratrol (RV), a natural compound found in various plants, has shown potential as a nanomedicine for lung cancer treatment. RV has varied effects on cancer cells, including promoting apoptosis by increasing pro-apoptotic proteins (Bax and Bak) and decreasing anti-apoptotic proteins (Bcl-2). It also hinders cell proliferation by influencing important signaling pathways (MAPK, mTOR, PI3K/Akt, and Wnt/β-catenin) that govern cancer progression. In addition, RV acts as a potent antioxidant, diminishing oxidative stress and safeguarding cells against DNA damage. However, using RV alone in cancer treatment has drawbacks, such as low bioavailability, lack of targeting ability, and susceptibility to degradation. In contrast, nanoparticle-based delivery systems address these limitations and hold promise for improving treatment outcomes in lung cancer; nanoparticle formulations of RV offer advantages such as improved drug delivery, increased stability, controlled release, and targeted delivery to lung cancer cells. This article will provide an overview of lung cancer, explore the potential of RV as a therapeutic agent, discuss the benefits and challenges of nanoparticle-based drug delivery, and highlight the promise of RV nanoparticles for cancer treatment, including lung cancer. By optimizing these systems for clinical application, future studies aim to enhance overall treatment outcomes and improve the prognosis for lung cancer patients.

25 January 2025 in Artificial Intelligence Review
Verified
Journal Article
Open access
PDF file
HSHamid Reza Saeidnia
Hamid Reza Saeidnia
FFFaezeh Firuzpour
Faezeh Firuzpour
MKMarcin Kozak
Marcin Kozak
HMHooman Soleymani majd
Hooman Soleymani majd
Cancer screening and diagnosis with the utilization of innovative Artificial Intelligence tools improved the treatment strategies and patients’ survival. With the rapid development of imaging technologies and the rise of artificial intelligence (AI), there is a significant opportunity to improve cancer diagnostics through the combination of image analysis and AI algorithms. This article provides a comprehensive review of studies that have investigated the application of AI-assisted image processing in cancer diagnosis. We searched the Web of Science and Scopus databases to identify relevant studies published between 2014 and January 2024. The search strategy utilized targeted keywords such as cancer diagnostics, image analysis, artificial intelligence, and advanced imaging techniques. We limited the review to articles written in English and using AI-assisted image processing in cancer diagnosis. The results show that by leveraging machine learning algorithms, including deep learning, computer-aided diagnosis systems have been developed that are efficient in detecting tumors, thereby facilitating early cancer detection. Additionally, various authors have explored the integration of personalized treatment approaches and precision medicine, allowing for the development of treatment plans tailored to individual patient characteristics and needs. The review emphasizes the potential of AI-assisted image processing in revolutionizing cancer diagnostics. The insights gained from this study contribute to the current understanding of the field and pave the way for future research and development aimed at advancing cancer diagnostics using image analysis and artificial intelligence.

4 July 2025 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
FFFaezeh Firuzpour
Faezeh Firuzpour
MBMaryam Barancheshmeh
Maryam Barancheshmeh
FZFariba Fallah Ziarani
Fariba Fallah Ziarani
LKLeila Karami
Leila Karami
CACena Aram
Cena Aram
Breast cancer (BC) remains a global health emergency, particularly HER2-positive subtypes, which are aggressive and resistant to conventional therapies. Despite advancements, therapeutic resistance and limited immune memory underline the need for novel treatment approaches such as multi-epitope vaccines. This study investigates the design and effectiveness of a novel in silico multi-epitope vaccine that is capable of targeting HER2 in breast cancer using immunoinformatics, structural modeling, and immune simulation approaches. UniProt was used to retrieve the HER2 protein sequences. Cytotoxic Tlymphocyte (CTL) and helper T lymphocyte (HTL) epitopes were predicted using IEDB and CTLPred, and filtered for antigenicity, IFN-γ production, and population coverage. The vaccine construct was designed by linking selected epitopes to PADRE, TAT peptide, and adjuvants using appropriate linker sequences. An evaluation of physicochemical, allergenic, and toxicological properties was carried out on the 322-amino-acid vaccine construct. Secondary and tertiary structures were predicted using PSIPRED and Robetta, refined with GalaxyRefine, and validated through Ramachandran plots, ERRAT, and ProSA-web. Molecular docking with TLR4 was conducted using HDOCK. Molecular dynamics simulations (MD) were performed with GROMACS for 100 ns and analyzed using RMSD, RMSF, PCA, DCCM, and MM-PBSA. Immune simulations were performed using C-ImmSim. The final vaccine construct was found to be non-allergenic, antigenic (VaxiJen score: 0.59) and stable (instability index: 23.18). Tertiary structure validation yielded a favorable Ramachandran distribution (83 %), an ERRAT score of 90.12, and a Z-score of −8.35. Docking showed strong binding to TLR4 (score:296.23, with 6 ion bridges and 7 hydrogen bonds). Stable conformation of the vaccine construct with low fluctuations and high interaction correlation was derived through MD simulations. MM-PBSA calculated a binding free energy of −112.71 kJ/mol. Immune simulations predicted robust humoral and cellular immune responses with increased IFN-γ, IL-2, CTLs, and memory B-cells. The proposed HER2-targeted multi-epitope vaccine confirmed promising immunogenicity, structural stability, and potential global population coverage. It represents a novel, rationally designed immunotherapy candidate against HER2-positive breast cancer. However, further in vitro and in vivo validations are required to confirm its clinical application.

29 October 2025 in BioImpacts
Verified
Journal Article
Open access
PDF file
FFFaezeh Firuzpour
Faezeh Firuzpour
MHMohammadAli Heydari
MohammadAli Heydari
CACena Aram
Cena Aram
AAAli Alishvandi
Ali Alishvandi
Breast cancer (BCA) remains the most prevalent cancer globally and the leading cause of cancer-related mortality among women, with rising incidence rates driven by genetic, lifestyle, and environmental factors. Early detection through precise screening is essential to improve prognosis and survival; yet, challenges persist, especially in resource-limited areas. Recent advances in Artificial Intelligence (AI), particularly machine learning and deep learning algorithms, have illustrated significant potential to enhance breast cancer screening, diagnosis, and treatment personalization. This review highlights the multifaceted role of AI in BCA management, encompassing its applications in image-based screening modalities, genomic and immunologic profiling, and drug discovery. AI-driven approaches offer diagnostic accuracy, cost-effectiveness, time-saving, and individualized treatment regimens. Despite promising developments, further research is crucial to overcome current challenges and regulatory hurdles in clinical settings. This article highlights the positive aspects of AI technologies in advancing BCA care and the importance of continued interdisciplinary research to optimize their implementations in breast cancer workflows.

13 January 2026 in Network Modeling Analysis in Health Informatics and Bioinformatics
Verified
Journal Article
Closed access
PDF file
AAAli Alishvandi
Ali Alishvandi
CACena Aram
Cena Aram
MBMaryam Barancheshemeh
Maryam Barancheshemeh
TSTara Shekari
Tara Shekari
FFFaezeh Firuzpour
Faezeh Firuzpour
MYMohammad Hossein Yazdi
Mohammad Hossein Yazdi

1 February 2025 in InfoScience Trends
Verified
Journal Article
Open access
PDF file
FFFaezeh Firuzpour
Faezeh Firuzpour
EAElaheh Abdolalipour
Elaheh Abdolalipour
NRNarjes Rezaeiroushan
Narjes Rezaeiroushan
MBMaryam Barancheshmeh
Maryam Barancheshmeh
NMNiloufar Moradi
Niloufar Moradi
HTHadiseh Shokouhi Targhi
Hadiseh Shokouhi Targhi
This study aims to explore physician confidence in artificial intelligence within the context of Iran's healthcare system. We aim to identify the factors influencing acceptance levels among physicians, particularly focusing on how job status and specialization impact attitudes toward AI. Specifically, we will investigate whether Type of specialization practitioners view AI differently relative to each other and whether academic physicians have distinct perspectives compared to their non-academic counterparts. By addressing these questions, we hope to contribute valuable insights that can facilitate the integration of AI technologies into medical practice and ultimately enhance healthcare delivery in Iran.This study aims to explore physician confidence in artificial intelligence within the context of Iran's healthcare system. We aim to identify the factors influencing acceptance levels among physicians, particularly focusing on how job status and specialization impact attitudes toward AI. Specifically, we will investigate whether Type of specialization practitioners view AI differently relative to each other and whether academic physicians have distinct perspectives compared to their non-academic counterparts. By addressing these questions, we hope to contribute valuable insights that can facilitate the integration of AI technologies into medical practice and ultimately enhance healthcare delivery in Iran.